Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche Shareholders Equity (Quarterly): 32.20B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 32.20B |
| June 30, 2024 | 32.20B |
| December 31, 2023 | 34.90B |
| June 30, 2023 | 29.49B |
| June 30, 2023 | 29.49B |
| December 31, 2022 | 30.19B |
| June 30, 2022 | 26.39B |
| June 30, 2022 | 26.39B |
| December 31, 2021 | 26.79B |
| June 30, 2021 | 41.06B |
| June 30, 2021 | 41.06B |
| December 31, 2020 | 41.60B |
| June 30, 2020 | 33.13B |
| June 30, 2020 | 33.13B |
| December 31, 2019 | 33.80B |
| June 30, 2019 | 28.72B |
| June 30, 2019 | 28.72B |
| December 31, 2018 | 28.06B |
| June 30, 2018 | 27.41B |
| June 30, 2018 | 27.41B |
| December 31, 2017 | 27.14B |
| June 30, 2017 | 23.88B |
| June 30, 2017 | 23.88B |
| December 31, 2016 | 23.50B |
| June 30, 2016 | 18.84B |
| Date | Value |
|---|---|
| June 30, 2016 | 18.84B |
| December 31, 2015 | 21.22B |
| June 30, 2015 | 18.47B |
| June 30, 2015 | 18.47B |
| December 31, 2014 | 19.81B |
| June 30, 2014 | 19.54B |
| June 30, 2014 | 19.54B |
| December 31, 2013 | 21.74B |
| June 30, 2013 | 14.76B |
| June 30, 2013 | 14.76B |
| December 31, 2012 | 15.90B |
| June 30, 2012 | 9.961B |
| June 30, 2012 | 9.961B |
| December 31, 2011 | 12.88B |
| June 30, 2011 | 10.60B |
| June 30, 2011 | 10.60B |
| December 31, 2010 | 10.13B |
| June 30, 2010 | 5.139B |
| December 31, 2009 | 7.113B |
| June 30, 2009 | 3.105B |
| December 31, 2008 | 41.62B |
| June 30, 2008 | 40.74B |
| June 30, 2008 | 40.74B |
| December 31, 2007 | 40.13B |
| June 30, 2007 | 34.74B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
26.39B
Minimum
Jun 2022
41.60B
Maximum
Dec 2020
32.79B
Average
32.20B
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 154.72M |
| CRISPR Therapeutics AG | 1.940B |
| Addex Therapeutics Ltd | 14.07M |
| NLS Pharmaceutics Ltd | -9.268M |
| Molecular Partners AG | 164.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.56B |
| Total Liabilities (Quarterly) | 69.98B |
| Debt to Equity Ratio | 1.19 |
| Current Ratio | 1.264 |
| Net Debt Paydown Yield | -1.66% |